KLRG1 and neoplasm: As ILC2s have three subsets, we hypothesized that ILC2s in TME would be tissue-specific. To test this, we further detected KLRG1 and ST2 expression in ILC2s residents in the normal spleen, tumor-bearing spleen, tumor-bearing lung tissue, and tumor tissue.